News

NAO: Care records 'four years behind schedule'

16-May-08

A key part of the National Programme for IT (NPfIT) is now four years behind schedule, say government auditors.

In a report out today, the National Audit Office says that the programme has made progress and its cost remains unchanged.

But it warned that the electronic Care Records Service, which allows doctors to access patients' medical histories, will not be ready until 2014-15 - four years later than planned. 

Dr Chaand Nagpaul, IT lead on the GPC, said that the programme's unrealistic deadlines had been ‘very damaging'.

‘Slipping deadlines for new IT systems and the premature release of systems that are not fit for purpose has [left] many doctors thoroughly disillusioned with the programme,' he said. 

The delays are largely due to problems in developing the Lorenzo system used in the North, Midlands and East of England. These problems have forced trusts to spend time and money on an interim system.

jonn.elledge@haymarket.com

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

A question of capacity

Medicolegal advisor, Dr John Holden addresses some dilemmas on consent that may be faced by GPs. Read more

Workplace-based assessment

The WPBA should be seen as a developmental process, says the RCGP's Dr Jane Mamelok. Read more

Professional development - The role of an educational supervisor

Working as an educational supervisor can be stimulating and rewarding, says Dr Alexander Williams. Read more

Show all articles

 

Latest Clinical Articles

Primary hyperparathyroidism

Contributed by Mr David Scott-Coombes, consultant endocrine surgeon at the University Hospital of Wa... Read more

Clinical Review - Headache in children

Contributed by Dr David Kernick, a GPSI in headache, based in Exeter. Read more

Carpal tunnel syndrome

Section 1: Epidemiology and aetiology Read more

Show all clinical articles

MIMS Product News

Toviaz

New drug - Toviaz

Pfizer has launched Toviaz (fesoterodine), a once-daily treatment for the symptoms of overactive bla... Read more

New drug - Tasigna

Novartis has launched Tasigna (nilotinib), a new antineoplastic agent for Philadelphia chromosome po... Read more

Ciproxin licensed for UTI in children

The licence for Ciproxin (ciprofloxacin) has been extended to include the second- and third-line tr... Read more

Jobs

 

Job of the Week